Operation Infinite Justice – Lifestyle
Author:
Shanghai Fosun Group-Shenzhen Hang Seng Hospital
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
April 28, 2026
Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
April 28, 2026
Fosun Pharma Announces 2025 Annual Results
March 24, 2026
Chinese medical team enables 30 type 1 diabetes patients to discontinue insulin through integrative medicine
March 12, 2026